Mar 5, 2026

Shares in several Finnish small caps fell this afternoon, following earnings updates, underperforming a slightly weaker broader market. For example, Tamtron Group, the weighing and material flow management technology provider, dropped 2.6% to EUR 5.36, while the OMX Helsinki 25 index slipped 0.15%.
Tamtron reported today that full-year 2025 revenue rose 5.5% to EUR 55.7 million, while operating profit fell to EUR 1.9 million from EUR 2.3 million. EBITDA edged up to EUR 5.9 million. Tamtron proposed a EUR 0.15 per share dividend and said it expects revenue and EBITDA to grow in 2026.
CEO Mikko Keskinen said the company reached a milestone despite weak demand in key markets. “We reached a milestone as revenue rose to an all-time high,” he said, highlighting acquisitions and investments in international sales.
Elsewhere, Orthex, a Nordic housewares manufacturer, fell 2.5% to EUR 4.64, also underperforming the market. For the full year, the company’s net sales slipped 2.8% to EUR 87.2 million, while earnings per share increased to EUR 0.38 from EUR 0.34. The board proposed a EUR 0.23 dividend per share, up from EUR 0.22.
CEO Alexander Rosenlew attributed weaker sales partly to cautious consumer behavior and shipment timing but said cost discipline supported profitability.
Nightingale Health, a blood biomarker testing technology company, slipped 0.7% to EUR 1.49. The group posted revenue of EUR 2.41 million for July–December 2025, up from EUR 2.31 million, while EBITDA loss widened to EUR 5.37 million and net loss totaled EUR 8.81 million. The company said it aims to increase revenue by at least 50% in the 2025–2026 financial year.
Shares in Herantis Pharma, a clinical-stage biotech developing treatments for Parkinson’s disease, fell 1.9% to EUR 2.04. The company reported a full-year net loss of EUR 6.6 million, compared with EUR 4.9 million in 2024, as research spending continued. CEO Antti Vuolanto said positive Phase 1b results for the HER-096 drug support plans to begin a Phase 2 trial in 2026.
Other top stories to read next

Stay on the pulse, catch the signals
Subscribe to Listeds Leadership Intelligence Platform:
leader and company database access
email alerts
career, boards and interim opportunities






